GlassScriptPhysician profile
Kristopher Jay Beickman
NPI 1164499026
$1,800.76
in general payments reported to CMS, 2019-2025
28 companies · $470 in 2025
The $470 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.05 · 2020: $86.30 · 2021: $147 · 2022: $447 · 2023: $278 · 2024: $301 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $246.84 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $173.70 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $170.87 | 2023-2025 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $162.78 | 2022 | |
| Mayne Pharma Commercial LLC | $118.65 | 2023-2025 | |
| Myovant Sciences INC. | $118.26 | 2021-2022 | |
| Organon LLC | $118.03 | 2022-2025 | Nexplanon |
| Abbvie INC. | $98.37 | 2021-2022 | |
| Astellas Pharma US INC | $90.72 | 2023-2025 | Veozah |
| Allergan, INC. | $56.91 | 2020 | |
| Agile Therapeutics, INC. | $48.79 | 2022-2024 | Twirla |
| Covidien LP | $45.85 | 2019 | |
| Shield Therapeutics INC | $45.18 | 2024 | |
| Sage Therapeutics, LLC | $39.43 | 2022-2023 | |
| Coopersurgical, INC. | $35.19 | 2019-2025 | Sos |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $31.84 | 2020-2025 | |
| Ethicon US, LLC | $22.72 | 2024 | Enseal X1 |
| Gynesonics, INC. | $20.97 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Daiichi Sankyo INC. | $20.08 | 2022 | |
| Hologic Sales and Service, LLC | $17.15 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Novo Nordisk INC | $17.08 | 2025 | Wegovy |
| Pacira Pharmaceuticals Incorporated | $16.58 | 2023 | Zilretta, Exparel, Iovera |
| Therapeuticsmd, INC. | $15.51 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.75 | 2022 | |
| Medtronic, INC. | $14.05 | 2025 | Ligasure |
| Phathom Pharmaceuticals, INC. | $13.66 | 2025 | Voquezna |
| Boston Scientific Corporation | $13.41 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Beickman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.